Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CSCO vs GSK✓SelectedUSD · GSKCSCO vs GSK performance historyLatest closeAs of-1.17%11/16
Stock and ETF performance explorer

CSCO vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+112.3%
GSK return
+64.4%
Excess return
+47.8%
Maximum drawdown
-27.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.2%-0.1%-1.1%-1.2%
7D-4.2%-1.3%-2.9%-4.1%
30D-12.0%+2.7%-14.7%-12.1%
3M-15.0%+2.7%-17.8%-15.1%
6M-19.4%+3.3%-22.8%-19.6%
YTD+25.0%+6.5%+18.5%+24.1%
1Y+23.4%+10.7%+12.8%+22.1%
3Y+112.3%+64.4%+47.9%+105.3%
All+112.3%+64.4%+47.8%+105.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling